Literature DB >> 9164440

Gene therapy of cancer.

R R Weichselbaum1, D Kufe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9164440     DOI： 10.1016/s0140-6736(97)90013-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene.

Authors:  T Goto; T Nishi; T Tamura; S B Dev; H Takeshima; M Kochi; K Yoshizato; J Kuratsu; T Sakata; G A Hofmann; Y Ushio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  A new delivery system for 5-fluorouracil using prodrug and converting enzyme.

Authors:  M Akimoto; T Miyahara; J Arai; A Akimoto; H Hamada; Y Yoshida; N Yoshimura
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

3.  Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector.

Authors:  S S Yoon; N M Carroll; E A Chiocca; K K Tanabe
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

Review 4.  Gene therapy for cancer: present status and future perspective.

Authors:  Magid H Amer
Journal:  Mol Cell Ther       Date:  2014-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.